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In her book The Alzheimer Conundrum: Entanglements of Dementia and Aging, Margaret Lock traces the 
history and politics of research on Alzheimer’s disease (AD). She begins with the discovery of the 
disease by Alois Alzheimer and its creation as a disease category (chapter 1) and then describes 
efforts to standardize AD given the continuous anomalies between neuropathology and symptoms 
(chapter 2). Lock analyses the shift towards the assessment of risk, especially through the 
identification of mild cognitive impairment (MCI, chapter 3), prodromal AD (chapter 4), genetic 
biomarkers (chapter 5), and genome-wide associations (chapter 6). She examines the effects of this 
focus on risk assessment on offspring of Alzheimer patients (chapter 7) and its role in the current 
interest in epigenetics (chapter 8). The first four chapters show, in detailed excerpts from scientific 
articles and quotations from interviews with researchers, the highly unsettled ontological status of 
AD: What is Alzheimer’s? When is something pathological? The later chapters describe a somewhat 
hesitant shift towards prevention.  
 
In her analysis Lock focuses on the role of uncertainty and (high-tech biomedical) reductionism in 
AD research. In particular, she examines the dominant and enduring position of localization theory, 
which tries to locate AD in changes in the brain and relate the disease to specific neuropathology. 
Investigators, consciously or unconsciously, embed this localization theory in their research. Lock 
describes how localization grounds the most prominent hypothesis on AD, the amyloid cascade 
theory, which posits that the accumulation of amyloid β (Aβ) protein in plaques is the first sign of 
AD that triggers deposition of tangles that eventually leads to symptoms.  
 
Lock traces the predominance of this hypothesis and its grounding in localization theory through an 
impressive exposé of AD research and discussions with prominent researchers. Lock shows that 
although attention has now shifted to twenty years prior to first symptoms, with research on MCI, 
genetic and epigenetic processes, and the hunt for biomarkers to identify disease (onset), this 
research is still based on the amyloid cascade hypothesis. In the tracing of research she demonstrates 
that AD research is primarily conducted in the United States, and addresses the precarious balance 
with research subjects in developing countries, especially when it comes to experimental 
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pharmaceutical interventions. One such example is a randomized controlled trial of a pharmaceutical 
intervention involving families in Antioquia, Colombia. This group of families carries a specific gene 
mutation that results in about one third among them developing early onset AD (manifest around 
the age of forty-five). Lock discusses the ethical dimensions of this trial as it relates to ‘the 
expanding universe of drug trials in which “naïve” subjects … often living in economically deprived 
conditions are systematically recruited for trials’ (p. 140). In these trials it is often unclear whether 
participants will benefit from the developments that they co-create. In the case of the Colombian 
trial, participants were asked to sign up for information and attend extensive information sessions, 
and the pharmaceutical company agreed that if a medicine would be developed the Colombian 
families would receive it. 
 
The Colombian trial is by some considered ‘a treasure trove’ in which studying predisposed, quite 
exceptional individuals will lead to a fuller understanding of the pathway of the disease, and in the 
end, make or break the amyloid cascade hypothesis. This is illustrative for the Alzheimer field that 
seems to be constantly anticipating a ‘breakthrough’ and looking for ‘silver bullets’. Some frame the 
hesitant move toward prevention as a Kuhnian paradigm shift, but Lock convincingly shows that 
research efforts in fact are a continuation of thinking within the framework of the amyloid cascade 
hypothesis; such a paradigm shift is actually nonexistent. Furthermore, uncertainty still pervades the 
research field. 
 
In the sidelines of The Alzheimer Conundrum lingers a critique of localization theory, the effects of a 
genetic focus on patients and family members, and the sometimes somewhat limited self-reflection 
of the researchers. She hints at a dogmatic following of localization theory and an unrelenting belief 
in the amyloid cascade hypothesis, almost as an implicit rationale within the AD community. 
However, Lock does this with utmost respect; she sees the vigorous activity, the efforts, and the 
well-hearted attempts, but at the same time raises ethical and philosophical questions. Particularly 
revealing is chapter 7 in which she interviews individuals who, in a clinical trial project, come to 
know about their genetic risk for AD. With laudable honesty she shows how this new information is 
integrated with previous ideas about their risk for and experience with the disease. For most 
participants knowledge of their genetic predisposition does not change how they perceive the risk of 
the disease. Rather, they envision their risk of genetic predisposition – and by extension, of disease – 
on the basis of likeness in character and appearance to a family member with the disease (p. 195). 
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This is an illuminating analysis of how people think about genetics and integrate genetic knowledge, 
and is of relevance to the wider scientific public dealing with biotechnological innovation.  
 
Throughout the book, Lock shows how decontextualized AD research is (although a glimpse of the 
contrary becomes visible now) and how environmental factors are rarely explicitly considered 
because the basic scientists (and perhaps funders) that lead AD research favor a more reductionist – 
localized – approach. As a result, the issues of caring for AD patients and environmental factors in 
AD remain neglected. But this point is not taken to the fullest. As decontextualized as the research 
feels, as decontextualized the book itself sometimes feels. Anthropologists might long for what is 
behind the stories, the human touch, the ordinary life, instead of interview excerpts and quotations 
from scientific articles. But then again, this is not what the book promises to do, and Lock’s 
approach to look at researchers themselves and trace the history of AD has rarely been 
accomplished in such a thorough way. 
 
We do not learn much about general processes that seem to be looming large: of a disease 
orientation, of a genetic focus, and of the money-making machine that seems to be intertwined with 
research on AD. These processes, and the involvement of pharmaceutical companies in medicine at 
large, remain decontextualized in the book and perhaps deserved some more attention. Lock shows 
deep understanding of AD research, but her findings could have been more embedded in wider 
developments showing the ‘entanglements’ of AD research. 
 
Lock also raises more general questions such as: What is ‘normal’ aging? Where and how do we 
draw boundaries? How do we place the continuous search for stabilizing disease markers 
throughout medicine, especially in light of aging and how we approach disease at later age? Similarly, 
how do we explicate the predominance of reductionism in research and funding that support it? The 
questions are there, but only touched upon, leaving the reader wishing for closer scrutiny of these 
kinds of questions.  
 
However, Lock’s social scientific critique is outstanding. She maintains analytical distance without 
neglecting the human burden of the disease and the genuine efforts that are made to understand and 
explore the disease. She never just critiques, and her call in the last chapter for attention to ‘social, 
political and environmental factors, including poverty, inequality, discrimination and racism’ (p. 229) 
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in the approach to AD is one that shows her engagement with the AD field and her concern for the 
people involved. 
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